2024. A Prospective, Randomized, Interventional Study Comparing Treatment Modalities for Diffuse Diabetic Macular Oedema: Bevacizumab and Bevacizumab Combined with Macular Grid - A Prospective Single Centre Study. Medical Forum Monthly. 28, 2 (May 2024).